npj Primary Care Respiratory Medicine · 2021 · 15 citations · 25 references
PharmacyInternal MedicinePharmacotherapyAllergyClinical PharmacologyDrug Utilization ReviewAsthma ManagementAsthma PharmacotherapyBronchodilator TherapyCombination Inhaler TherapyRespiratory MedicineAsthma Maintenance TherapyCohort Study InvestigationGuideline-based TherapyHealthcare Resource UtilizationHealthcare Utilization MeasurementInhaled Corticosteroid AdministrationInhaled Corticosteroid CombinationsLong-acting Beta Agonists
-agonist (ICS/LABA). Patients (≥12 years) with ≥2 asthma diagnoses, newly initiated on medium-/high-dose ICS/LABA (Japanese asthma guidelines), from 01 April 2009 to 31 March 2015 were included, using Japan Medical Data Center Claims Database. Primary objective: proportion of patients with uncontrolled asthma in the year following ICS/LABA initiation. Secondary objectives: predictors of uncontrolled asthma and healthcare resource utilization. In medium-dose (N = 24,937) and high-dose (N = 8661) ICS/LABA cohorts, 23% and 21% patients, respectively, were uncontrolled. Treatment step up and exacerbation were most common indicators of uncontrolled asthma. Predictors of uncontrolled asthma, analyzed by multivariable Cox model, included systemic corticosteroid use, exacerbation history, comorbidities, and being female. In both cohorts, healthcare resource utilization was higher in patients with uncontrolled asthma. Over 20% patients with persistent asthma who initiated medium- or high-dose ICS/LABA were uncontrolled, highlighting unmet need for novel therapies in these patients.
25
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations
Pharmacy, Chronic Disease Prevention, Preventive Medicine +10
Joan B. Soriano, Amanuel Alemu Abajobir, Kalkidan Hassen Abate et al. · The Lancet Respiratory Medicine · 2017 · 2.6K citations · Full text
Public Health, Chronic Disease Control, Chronic Disease Prevention +17
Why Test for Proportional Hazards?
Mats Julius Stensrud, Miguel A. Hernán · JAMA · 2020 · 551 citations · Full text